DCF — KERN MEDICAL CENTER
Enterprise Value: $-241.6M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-241.6M
Enterprise Value
$-80.8M
PV of Cash Flows
$-160.8M
PV of Terminal Value
$-259.0M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $281.4M | $-12.7M | -5.0% | $-24.6M | $-22.3M |
| Year 2 | $289.9M | $-10.1M | -4.0% | $-22.4M | $-18.5M |
| Year 3 | $298.6M | $-7.5M | -3.0% | $-20.1M | $-15.1M |
| Year 4 | $307.5M | $-6.2M | -2.0% | $-19.2M | $-13.1M |
| Year 5 | $316.7M | $-5.5M | -2.0% | $-19.0M | $-11.8M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-241.6M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$273.2M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.05000000109801579
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5